Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Unravelling the role of complement in progressive chronic kidney disease

FY 2023-24

Summary
Each time the heart pumps, roughly a quarter of the blood flows through the kidneys, where it is filtered by tiny filtration units within each kidney. These filters prevent large molecules, such as proteins, from entering the urinary space. Some conditions can result in these filters becoming “leaky”, allowing proteins to leak into the urine. This process is called proteinuria. During proteinuria, escaped proteins send signals to try and repair the kidneys, however, this eventually backfires and the kidneys become scarred. Over time, the scarring accumulates and kidney function progressively declines. Eventually, the kidneys become nonfunctional and the patient now requires costly renal replacement therapies (RRTs), such as dialysis and kidney transplant. It has recently been proposed that the progression of kidney damage involving proteinuria may be influenced by the complement system, a part of the immune system normally involved in the defense against invading pathogens. As the kidney filters weaken, proteins present in the blood, including complement proteins, leak into the urinary space and contribute significantly to kidney scarring. Therefore, the aim of this study is to establish the potential beneficial effects of complement inhibition in progressive kidney damage. Using a pharmacological toxin, proteinuria will be induced in healthy and complement knockout mice. Experiments will be conducted to determine the effects of complement inhibition on kidney scarring and function. The results of this study would be clinically significant as it has the potential to identify complement inhibition as a new treatment for delaying progressive kidney damage associated with proteinuria. Ultimately, this study may contribute to reducing the financial burden of costly RRTs.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506047
Name
Fu Vienna
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Unravelling the role of complement in progressive chronic kidney disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
C3; Complement; Fibrosis; Inflammation; Kidney Disease; Knock-Out; Mouse; Progressive; Proteinuria; Renal Failure
Abstract
Each time the heart pumps, roughly a quarter of the blood flows through the kidneys, where it is filtered by tiny filtration units within each kidney. These filters prevent large molecules, such as proteins, from entering the urinary space. Some conditions can result in these filters becoming “leaky”, allowing proteins to leak into the urine. This process is called proteinuria. During proteinuria, escaped proteins send signals to try and repair the kidneys, however, this eventually backfires and the kidneys become scarred. Over time, the scarring accumulates and kidney function progressively declines. Eventually, the kidneys become nonfunctional and the patient now requires costly renal replacement therapies (RRTs), such as dialysis and kidney transplant. It has recently been proposed that the progression of kidney damage involving proteinuria may be influenced by the complement system, a part of the immune system normally involved in the defense against invading pathogens. As the kidney filters weaken, proteins present in the blood, including complement proteins, leak into the urinary space and contribute significantly to kidney scarring. Therefore, the aim of this study is to establish the potential beneficial effects of complement inhibition in progressive kidney damage. Using a pharmacological toxin, proteinuria will be induced in healthy and complement knockout mice. Experiments will be conducted to determine the effects of complement inhibition on kidney scarring and function. The results of this study would be clinically significant as it has the potential to identify complement inhibition as a new treatment for delaying progressive kidney damage associated with proteinuria. Ultimately, this study may contribute to reducing the financial burden of costly RRTs.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fu, Vienna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~